Fortress Biotech Inc.

NASDAQ: FBIO · Real-Time Price · USD
2.13
0.17 (8.67%)
At close: Aug 15, 2025, 3:59 PM
2.10
-1.39%
After-hours: Aug 15, 2025, 05:56 PM EDT

Fortress Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
13.14M 15.12M 14.63M 14.9M 13.03M 19.95M 34.75M 17.39M 12.43M 16.4M 16.53M 18.89M 23.93M 18.28M 21.09M 17.84M 11.59M
Cost of Revenue
4.79M 2.24M 5.29M 6.54M 6M 6.01M 6.43M 7.77M 6.45M 7.72M 7.22M 7.63M 8.2M 9.53M 11.17M 7.48M 3.91M
Gross Profit
8.35M 12.88M 9.34M 8.36M 7.03M 13.93M 28.32M 9.62M 5.98M 8.69M 9.31M 11.25M 15.72M 8.75M 9.92M 10.36M 7.68M
Operating Income
-22.32M -23.84M -22.09M -27.79M -36.57M -19.61M -13.76M -50.1M -58.87M -54M -50.06M -50.93M -47.27M -62M -49.92M -42.86M -30.02M
Interest Income
490K 526K 589K 734K 833K 707K 547K 715K 1.04M 687K 419K 150K 142K 144K 132K 146K 227K
Pretax Income
-24.69M -25.98M -26.63M -28.82M -39.02M -28.61M -10.58M -59.3M -55.15M -57M -53.06M -53.93M -49.48M -68.03M -45.86M -24.39M -26.07M
Net Income
-10.58M -6.76M -12.87M -10.95M -15.42M -9.28M -5.04M -24.78M -21.54M -26.95M -22.51M -21.36M -15.76M -31.57M -20.78M -3.54M -8.82M
Selling & General & Admin
25.66M 26.86M 21.99M 20.82M 17.94M 22.61M 21.73M 24.44M 25.34M 28.2M 30.14M 29.05M 26.27M 27.7M 22.22M 19.38M 17.54M
Research & Development
3.94M 9.94M 9.45M 12.67M 24.84M 14.08M 20.35M 32.14M 39.51M 35.12M 29.9M 33.13M 36.72M 43.05M 28.08M 33.83M 20.15M
Other Expenses
1.06M -86K n/a 2.65M 814K -3.14M n/a 3.14M n/a -635K -669K 1K n/a n/a 9.54M n/a 126K
Operating Expenses
30.67M 36.72M 31.44M 36.14M 43.59M 33.55M 42.08M 59.72M 64.85M 62.69M 59.37M 62.18M 62.99M 69.99M 59.84M 53.22M 37.7M
Interest Expense
2.81M 2.59M 6.21M 2.12M 2.6M 2.06M 2.53M 3.63M 4.3M 4.75M 3.39M 3.15M 2.35M 5.92M 4.44M 2.76M 2.19M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
35.46M 38.95M 36.72M 42.68M 49.6M 39.56M 48.51M 67.49M 71.3M 70.4M 66.59M 69.81M 71.19M 80.28M 61.47M 60.7M 41.6M
Income Tax Expense
n/a 336K 69K n/a n/a 379K 141K n/a n/a 449K -35.44M n/a n/a 473K n/a n/a n/a
Shares Outstanding (Basic)
26.45M 20.24M 19.7M 18.32M 17.15M 7.8M 7.5M 7.38M 6.79M 5.62M 5.96M 5.92M 5.75M 5.58M 5.42M 5.4M 5.39M
Shares Outstanding (Diluted)
26.45M 20.24M 19.7M 18.32M 17.15M 7.8M 7.5M 7.38M 6.79M 6.04M 5.96M 5.92M 5.76M 5.58M 5.42M 5.4M 5.39M
EPS (Basic)
-0.48 -0.33 -0.76 -0.73 -1.03 -1.19 -0.94 -3.65 -3.47 -7.8 -4.11 -3.9 -2.7 -5.66 -3.83 -0.65 -1.64
EPS (Diluted)
-0.48 -0.33 -0.76 -0.73 -1.03 -1.19 -0.94 -3.65 -3.47 -7.8 -4.11 -3.9 -2.7 -5.66 -3.83 -0.65 -1.64
EBITDA
-20.99M -20.11M -21.07M -26.14M -35.84M -25.38M -5.95M -52.4M -49.91M -51.38M -47.86M -49.11M -44.93M -60.44M -39.68M -20.45M -22.27M
EBIT
-22.18M -19.1M -24.39M -27.33M -37.03M -27.09M -8.71M -54.1M -51.83M -53.98M -50.22M -51.33M -47.13M -62.12M -42.14M -22.23M -24.19M
Depreciation & Amortization
1.19M 1.13M 3.32M 1.19M 1.19M 1.71M 2.75M 1.7M 1.91M 2.59M 2.34M 2.22M 2.2M 1.68M 1.74M 1.77M 1.6M